MENU
+Compare
GLMD
Stock ticker: NASDAQ
AS OF
Oct 14, 12:04 PM (EDT)
Price
$1.43
Change
-$0.05 (-3.40%)
Capitalization
8.05M

GLMD Galmed Pharmaceuticals Ltd Forecast, Technical & Fundamental Analysis

Galmed Pharmaceuticals Ltd is a biopharmaceutical company... Show more

GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GLMD with price predictions
Oct 08, 2025

GLMD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for GLMD turned positive on October 01, 2025. Looking at past instances where GLMD's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GLMD's RSI Oscillator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on GLMD as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

GLMD moved above its 50-day moving average on October 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GLMD crossed bullishly above the 50-day moving average on October 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where GLMD advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 70 cases where GLMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GLMD broke above its upper Bollinger Band on September 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.392) is normal, around the industry mean (23.456). P/E Ratio (0.019) is within average values for comparable stocks, (54.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.164). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (347.799).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GLMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GLMD is expected to report earnings to rise 25.40% to -79 cents per share on November 10

Galmed Pharmaceuticals Ltd GLMD Stock Earnings Reports
Q3'25
Est.
$-0.79
Q2'25
Beat
by $0.20
Q3'23
Beat
by $0.03
Q2'23
Est.
$-0.34
Q1'23
Beat
by $0.41
The last earnings report on August 28 showed earnings per share of -62 cents, beating the estimate of -82 cents. With 34.66K shares outstanding, the current market capitalization sits at 8.05M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFS18.890.42
+2.27%
Provident Financial Services
OFIX14.500.30
+2.11%
Orthofix Medical
SCKT0.970.02
+2.03%
Socket Mobile
TKO188.601.55
+0.83%
TKO Group Holdings
EXOZ12.990.04
+0.31%
eXoZymes Inc

GLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been loosely correlated with NUVL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+3.52%
NUVL - GLMD
41%
Loosely correlated
+1.87%
HXBM - GLMD
38%
Loosely correlated
N/A
REVB - GLMD
31%
Poorly correlated
-5.63%
ATHE - GLMD
30%
Poorly correlated
+8.62%
RVMD - GLMD
30%
Poorly correlated
+1.06%
More